| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |